Breathing blues? Give puffs a pass to reduce the risk of attacks
Asthma care needs to be reviewed as patients tend to rely on short-acting rather than maintenance drugs: experts
The Global Asthma Initiative (Gina), which works with healthcare professionals and public health officials to reduce the prevalence of the condition globally, has recommended that current treatment be re-examined.
According to Gina, its recent updated recommendations have overturned decades of asthma care and represent the most significant change in the management of it in more than 30 years.
The link between SABA blue reliever inhalers over-reliance by asthma sufferers and an increased risk of asthma attacks has led to updated recommendations...